These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 24916143)

  • 21. Tympanic membrane changes in central tympanic membrane perforations.
    Oktay MF; Cureoglu S; Schachern PA; Paparella MM; Kariya S; Fukushima H
    Am J Otolaryngol; 2005; 26(6):393-7. PubMed ID: 16275408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence of tympanic membrane and related middle ear pathology in children: a large longitudinal cohort study followed from birth to age ten.
    Maw AR; Hall AJ; Pothier DD; Gregory SP; Steer CD
    Otol Neurotol; 2011 Oct; 32(8):1256-61. PubMed ID: 21897314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the function of the pars flaccida: retraction of the pars flaccida and buffering of negative middle ear pressure.
    Sadé J
    Acta Otolaryngol; 1997 Mar; 117(2):289-92. PubMed ID: 9105468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of retraction pockets in cholesteatoma development: an ultrastructural study.
    Akyildiz N; Akbay C; Ozgïrgïn ON; Bayramoglu I; Sayin N
    Ear Nose Throat J; 1993 Mar; 72(3):210-2. PubMed ID: 8482265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative assessment of taste function in patients with middle ear disease.
    Sakaguchi A; Katsura H; Nin T; Adachi O; Mishiro Y; Daimon T; Sakagami M
    Otol Neurotol; 2012 Jul; 33(5):761-4. PubMed ID: 22664899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The motility of keratinocytes in cholesteatoma: an ultrastructural approach to epithelial migration.
    Robinson AC; Hawke M
    J Otolaryngol; 1991 Oct; 20(5):353-9. PubMed ID: 1960792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pars flaccida middle ear pressure and mastoid pneumatization index.
    Sadé J; Fuchs C; Luntz M
    Acta Otolaryngol; 1996 Mar; 116(2):284-7. PubMed ID: 8725533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The collagen structure of the tympanic membrane: collagen types I, II, and III in the healthy tympanic membrane, during healing of a perforation, and during infection.
    Stenfeldt K; Johansson C; Hellström S
    Arch Otolaryngol Head Neck Surg; 2006 Mar; 132(3):293-8. PubMed ID: 16549750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Development of cholesteatoma in the middle ear ab statu nascendi].
    Schwarz M
    HNO; 1985 Apr; 33(4):180-2. PubMed ID: 3997580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear.
    Schilling V; Negri B; Bujía J; Schulz P; Kastenbauer E
    Am J Otol; 1992 Jul; 13(4):350-5. PubMed ID: 1384343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gerbilline cholesteatoma development Part III. Increased proliferation index of basal keratinocytes of the tympanic membrane and external ear canal.
    Tinling SP; Chole RA
    Otolaryngol Head Neck Surg; 2006 Jul; 135(1):116-23. PubMed ID: 16815195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental induction of middle ear cholesteatoma in rats.
    Huang CC; Shi GS; Yi ZX
    Am J Otolaryngol; 1988; 9(4):165-72. PubMed ID: 3265859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experimentally produced cholesteatoma (author's transl)].
    Steinbach E
    Laryngol Rhinol Otol (Stuttg); 1978 Aug; 57(8):724-33. PubMed ID: 682791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total mastoid obliteration in staged canal-up tympanoplasty for cholesteatoma facilitates tympanic aeration.
    Yanagihara N; Komori M; Hinohira Y
    Otol Neurotol; 2009 Sep; 30(6):766-70. PubMed ID: 19704361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the pars flaccida in the mechanics of the middle ear.
    Stenfors LE; Salén B; Winblad B
    Acta Otolaryngol; 1979; 88(5-6):395-400. PubMed ID: 532615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adhesive process and cholesteatoma in the sequel of tubal disfunction (author's transl)].
    Zechner G
    Laryngol Rhinol Otol (Stuttg); 1980 Mar; 59(3):179-84. PubMed ID: 7442402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interleukin-1-containing cells in cholesteatoma of the middle ear].
    Schilling V; Bujia J; Negri B; Kastenbauer E
    Laryngorhinootologie; 1992 May; 71(5):271-5. PubMed ID: 1616549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Otoendoscopy in cholesteatoma surgery of the middle ear: what benefits can be expected?
    Ayache S; Tramier B; Strunski V
    Otol Neurotol; 2008 Dec; 29(8):1085-90. PubMed ID: 18836388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors for sensorineural hearing loss in patients with tubotympanic otitis, cholesteatoma, and tympanic membrane retractions.
    Jesic SD; Jotic AD; Babic BB
    Otol Neurotol; 2012 Aug; 33(6):934-40. PubMed ID: 22722145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal bone histopathology in chronically infected ears with intact and perforated tympanic membranes.
    da Costa SS; Paparella MM; Schachern PA; Yoon TH; Kimberley BP
    Laryngoscope; 1992 Nov; 102(11):1229-36. PubMed ID: 1405982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.